Related Experiment Video
Updated: Jul 13, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Identification of two herbal compounds with potential cholesterol-lowering activity
Yilin Zhang1, Haiqing Zhang, Shineng Hua
1Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China.
Biochemical Pharmacology
|August 4, 2007
Summary
Two novel compounds, Daphnetoxin and Gniditrin, were identified from Daphne giraldii Nitsche. These compounds activate the low-density lipoprotein receptor (LDLR) promoter, offering potential for new cholesterol-lowering drug development.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- The low-density lipoprotein receptor (LDLR) is crucial for regulating plasma LDL-cholesterol levels.
- Gene regulation of LDLR occurs via sterol-responsive element (SRE) and sterol-independent responsive element (SIRE).
Purpose of the Study:
- To identify novel cholesterol-lowering compounds from a Chinese herb library.
- To investigate compounds that activate LDLR promoter activity.
Main Methods:
- High-throughput screening using an LDLR promoter activation assay.
- Characterization of identified compounds' effects on LDLR mRNA and expression.
Main Results:
- Two compounds, Daphnetoxin and Gniditrin, were isolated from Daphne giraldii Nitsche.
- These compounds were shown to activate the LDLR promoter.
- Daphnetoxin and Gniditrin increased LDLR mRNA levels and up-regulated LDLR expression.
Conclusions:
- Daphnetoxin and Gniditrin represent a new class of compounds that activate LDLR promoter.
- These herbal compounds show promise for the development of novel cholesterol-lowering therapeutics.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...